Trial intelligence / Profile preview

Remimazolam vs Propofol Sedation for Third Molar Extraction

KCT0009638Phase 4Recruiting

Sponsor
Seoul National University Dental Hospital
Start
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of remimazolam, propofol in impacted tooth, sponsored by Seoul National University Dental Hospital. Started Dec 2023; status: recruiting.

02

Drugs

remimazolampropofol
03

Conditions

impacted tooth

Beyond the preview

Go deeper on KCT0009638.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0009638.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call